Asia’s leading medical image AI solution provider, aetherAI is dedicated to cutting-edge solutions for digital pathology transformation, AI-powered diagnostic support systems, and biopharma enterprise services. By leveraging state-of-the-art technologies, aetherAI aims to ease the burden on healthcare professionals and improve diagnostic imaging quality. At the forefront of digital pathology AI, aetherAI has partnered with top medical centers in the US, Taiwan, and Japan, including UPMC, National Taiwan University Hospital, Kanazawa University, etc. aetherAI is also a trusted collaborator for such BioPharma companies as Novartis Taiwan and ACT Genomics, and many more to accelerate AI applications for research efficiency.
